[Federal Register Volume 76, Number 27 (Wednesday, February 9, 2011)]
[Notices]
[Page 7216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2848]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health Statement of Organization, 
Functions, and Delegations of Authority

    Part N, National Institutes of Health, of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (40 FR 22859, May 27, 1975, as 
amended most recently at 66 FR 6617, January 22, 2001, and redesignated 
from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as 
set forth below to establish the Office of Portfolio Analysis (OPA) and 
Office of Program Evaluation and Performance (OPEP) within the Division 
of Program Coordination, Planning and Strategic Initiative (DPCPSI) 
within the Office of the Director.
    Section N-AW, Organization and Functions, is amended as follows: 
Immediately after the paragraph headed ``Office of Portfolio Analysis 
and Strategic Initiatives'' (N AW6, formerly HN AW6), insert the 
following:
    Office of Portfolio Analysis (N AW7, formerly N AW7) (1) Prepare 
and analyze data on NIH sponsored biomedical research to inform trans-
NIH planning and coordination; (2) serve as a resource for portfolio 
management at the programmatic level; (3) employ databases, analytic 
tools, methodologies and other resources to conduct assessments in 
support of portfolio analyses and priority setting in scientific areas 
of interest across NIH; (4) research and develop new analytic tools, 
support systems, and specifications for new resources in coordination 
with other NIH organizations to enhance the management of the NIH's 
scientific portfolio; and (5) provide, in coordination with other NIH 
organizations, training on portfolio analysis tools, procedures, and 
methodology.
    Office of Program Evaluation and Performance (N AW8, formerly N 
AW8) (1) Plan, conduct, coordinate, and support program evaluations, 
including IC-specific program and project evaluations and trans-NIH 
evaluations; (2) manage and administer NIH's Evaluation Set-Aside 
Program; (3) coordinate and direct the preparation of plans and reports 
required by the Government Performance and Results Act (GPRA), 
including the development of required performance measures; (4) 
identify and advise on emerging national issues within program 
evaluation and performance, including NIH's response to legislative, 
regulatory, and policy requirements of the GPRA and administration of 
the NIH-wide evaluation program.
    Delegations of Authority Statement: All delegations and 
redelegations of authority to officers and employees of NIH that were 
in effect immediately prior to the effective date of this 
reorganization and are consistent with this reorganization shall 
continue in effect, pending further redelegation.

    Dated: January 21, 2011.
LaVerene Stringfield,
Associate Director for Management, OD, ES, NIH.
[FR Doc. 2011-2848 Filed 2-8-11; 8:45 am]
BILLING CODE 4140-01-P